Community hub
Article
Video

Scaling Home-Based Diagnostics in Decentralized Healthcare

Overview:

  • The global healthcare ecosystem is rapidly shifting toward decentralized care models, with home-based diagnostics emerging as a key pillar. This trend supports chronic care management, reduces hospital load, and empowers patients.
  • Demand for at-home testing is growing due to post-COVID behavioral shifts, provider shortages, and the rise of telemedicine platforms.
  • Innovations in POC diagnostics, digital enrollment tools, and wearable-enabled monitoring are facilitating remote, patient-centric diagnostic experiences.

Market Size & Growth 

  • The global at-home testing market is projected to reach USD 11.88 billion by 2035, up from USD 7.79 billion in 2025, achieving a CAGR of ~4.8%.
  • The broader Point-of-Care (POC) diagnostics market is projected to reach USD 68.5 billion by 2030, up from USD 47.8 billion in 2024, with a CAGR of ~5.8%.
  • Nova One estimates a sharp rise in the primary care POC market, projecting USD 213.16 billion by 2034 from a base of USD 27.25 billion in 2024, reflecting a CAGR of ~22.8%.

Key Growth Drivers

  • The growing global burden of chronic diseases and aging populations are driving demand for early, continuous, and decentralized testing options.
  • Patient preference for convenience, privacy, and access has accelerated the shift toward home-based diagnostics post-pandemic.
  • Government policies and payer incentives are increasingly aligned with decentralized, cost-effective testing that reduces hospital burden.

M&A Overview

  • The sector has seen rising interest from private equity and strategic acquirers, especially in enabling platforms that offer scalability, regulatory compliance, and data integration capabilities.
  • Deals are consolidating the fragmented POC and home diagnostics space, particularly in telehealth-integrated diagnostics.
  • Startups with digital enrollment, AI-driven analytics, and chronic disease alignment are key M&A targets due to their data defensibility and remote care enablement.

AI’s Role

  • The AI-enabled diagnostics is projected to reach USD 10.28 billion by 2034, rising from USD 1.61 billion in 2024, reflecting a CAGR of ~20.4%.
  • AI is increasingly used to harmonize data from EHRs, wearables, and apps—supporting real-time triage and diagnostic accuracy.
  • AI’s predictive analytics tools help flag disease progression earlier, reducing emergency episodes and improving chronic care outcomes.

Competitive Landscape

  • Clario and other digital-first POC platforms are gaining market share by enabling decentralized clinical trials and FDA-aligned data collection.
  • Established diagnostics players are investing in remote patient monitoring and SaaS integrations to remain competitive.
  • Startups offering modular, scalable platforms with strong clinical validation and reimbursement alignment are attracting VC and PE funding.

Sources: Future Market Insights, Grand View Research, Nova One Advisor, Coherent Market Insights, Market.us, Biospace, LinkedIn Insights

Stay current with our latest insights
Let’s stay connected
Submit
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.